NUS Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

7.160

Open

6.635

VWAP

6.89

Vol

784.40K

Mkt Cap

347.98M

Low

6.340

Amount

5.40M

EV/EBITDA(TTM)

2.83

Total Shares

48.60M

EV

375.29M

EV/OCF(TTM)

4.94

P/S(TTM)

0.25

Nu Skin Enterprises, Inc. develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. It has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its beauty & skincare solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lines and wrinkles, and oily skin and pores. Its health & wellness solutions include gut health, bone and joint health, brain health, energy and stamina, heart health, immunity support, and protein and fitness. It offers various beauty devices, including ageLOC LumiSpa, Nu Skin RenuSpa iO and Prysm iO. Its ageLOC LumiSpa includes products such as LumiSpa iO Superpower Kit, ageLOC Rose Gold LumiSpa iO, LumiSpa Rose Gold Accent Twin Pack, and others.

Show More

Events Timeline

(ET)

2026-05-07

16:10:00

Sees Q2 Revenue of $330M-$360M

2026-05-07

16:10:00

Nu Skin Q1 Revenue at $320.6M, Below Estimate

2026-05-07

16:10:00

Company Confirms FY26 Revenue Outlook of $1.35B to $1.5B

2026-03-20 (ET)

2026-03-20

16:10:00

Nu Skin Appoints Chelsea Lantz as Interim CFO

2026-03-09 (ET)

2026-03-09

16:10:00

Nu Skin Appoints Chayce Clark as Chief Operating Officer

2026-02-12 (ET)

2026-02-12

16:20:00

Sees FY26 Revenue of $1.35B to $1.50B

2026-02-12

16:10:00

Nu Skin Reports Q4 Revenue of $370.3M

2026-02-12

16:10:00

Sees Q2 Revenue of $320M to $340M

2025-11-06 (ET)

2025-11-06

16:28:39

Nu Skin projects FY25 EPS between $3.15 and $3.25

2025-11-06

16:28:12

Nu Skin Projects Q4 EPS Between 25c and 35c

News

NASDAQ.COM

05-08NASDAQ.COM

Nu Skin (NUS) Q1 2026 Earnings Transcript

seekingalpha

05-08seekingalpha

Nu Skin Enterprises Q1 2026 Earnings Call Insights

Newsfilter

04-02Newsfilter

Nu Skin Launches Prysm iO Intelligent Wellness Platform

CNBC

Thorne Brand Experiences Rapid Growth Driven by Gen Z

seekingalpha

03-20seekingalpha

Nu Skin Appoints Chelsea Lantz as Interim CFO Following Departure of James Thomas

Newsfilter

03-20Newsfilter

Nu Skin Appoints Chelsea Lantz as Interim CFO

Valuation Metrics

The current forward P/E ratio for NU Skin Enterprises Inc (NUS.N) is 7.34, compared to its 5-year average forward P/E of 11.80. For a more detailed relative valuation and DCF analysis to assess NU Skin Enterprises Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

11.80

Current PE

7.34

Overvalued PE

16.52

Undervalued PE

7.09

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

5.77

Current EV/EBITDA

2.90

Overvalued EV/EBITDA

8.76

Undervalued EV/EBITDA

2.78

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

0.59

Current PS

0.23

Overvalued PS

0.93

Undervalued PS

0.26

Financials

AI Analysis

Annual

Quarterly

Whales Holding NUS

Castleknight Management LP

Trading Trends

People Also Watch

Frequently Asked Questions

What is NU Skin Enterprises Inc (NUS) stock price today?

The current price of NUS is 7.16 USD — it has increased 1.99

What is NU Skin Enterprises Inc (NUS)'s business?

Nu Skin Enterprises, Inc. develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. It has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its beauty & skincare solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lines and wrinkles, and oily skin and pores. Its health & wellness solutions include gut health, bone and joint health, brain health, energy and stamina, heart health, immunity support, and protein and fitness. It offers various beauty devices, including ageLOC LumiSpa, Nu Skin RenuSpa iO and Prysm iO. Its ageLOC LumiSpa includes products such as LumiSpa iO Superpower Kit, ageLOC Rose Gold LumiSpa iO, LumiSpa Rose Gold Accent Twin Pack, and others.

What is the price predicton of NUS Stock?

Wall Street analysts forecast NUS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NUS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is NU Skin Enterprises Inc (NUS)'s revenue for the last quarter?

NU Skin Enterprises Inc revenue for the last quarter amounts to 320.61M USD, decreased -12.04

What is NU Skin Enterprises Inc (NUS)'s earnings per share (EPS) for the last quarter?

NU Skin Enterprises Inc. EPS for the last quarter amounts to 0.04 USD, decreased -98.13

How many employees does NU Skin Enterprises Inc (NUS). have?

NU Skin Enterprises Inc (NUS) has 2800 emplpoyees as of May 10 2026.

What is NU Skin Enterprises Inc (NUS) market cap?

Today NUS has the market capitalization of 347.98M USD.